Key Takeaways From Globus Medical Analyst Ratings
Key Takeaways From Globus Medical Analyst Ratings
Globus 醫學分析師評級的關鍵要點
Globus Medical (NYSE:GMED) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Globus Medical（紐約證券交易所代碼：GMED）在上個季度接受了7位分析師的分析，揭示了從看漲到看跌的一系列觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $66.0, with a high estimate of $85.00 and a low estimate of $60.00. Marking an increase of 3.94%, the current average surpasses the previous average price target of $63.50.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲66.0美元，最高估計爲85.00美元，低估值爲60.00美元。目前的平均價格上漲了3.94％，超過了之前的平均目標股價63.50美元。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析師評級：深度分析
The analysis of recent analyst actions...
對分析師最近...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。